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Editorial
We are living in a world with constant social, 
economic, and demographic change: rapid mobility 
of a large contingent of people over long distances in 
the short period of time; social imbalance; populations 
deprived of liberty and refugees; poor vaccine coverage; 
and changes in the climate and ecosystems that favor 
vector proliferation and circulation of agents (mainly 
viral) are some examples of factors that interact as a 
puzzle to explain the variety of epidemics that have 
been experienced in recent years worldwide.1
In Brazil, we have been in the midst of a hurricane 
of emerging and re-emerging disease epidemics 
over the past 35 to 40 years, especially in the last 
4 to 5 years, which was worthy of an editorial in the 
New England Journal of Medicine, entitled “... Once 
Again on the Radar Screen ... ”2 Examples include 
AIDS, dengue, leptospirosis, rubella, and measles 
in the 1980s and 1990s; dengue and H1N1 in the 
2000s; annual dengue epidemics and the emergence 
of Chikungunya and Zika from 2014 to 2019; and the 
re-emergence of yellow fever, respiratory syncytial virus 
and measles from 2017 to 2019 (Figure 1).
In addition, in recent years, we have seen the 
resurgence of sexually transmitted diseases, such as 
HIV infection among young people; syphilis, with a 
large number of maternal-fetal cases; and sexually 
transmitted hepatitis A and B—not forgetting 
tuberculosis and leprosy, which are far from being 
considered eradicated or under low endemic levels.
This whole scenario makes the pathology of 
infectious diseases important, not only in Brazil, 
but worldwide. For instance, in the case of Zika, 
it was essential to understand the disease early in 
the epidemic through the autopsy case report of a 
conceptus with microcephaly, whose mother acquired 
the disease in northeastern Brazil. It was possible to 
describe macroscopy and microscopy of the brain in 
detail, to observe the agent by immunofluorescence 
and electron microscopy in the lesions, and to 
sequence the viral strain obtained in the brain tissue, 
determining its phylogeny.3 Subsequently, works by 
Chimelli et al.4 and Martines et al.5 demonstrated that 
the Zika virus can produce a myriad of lesions in the 
central and peripheral nervous system due to a change 
in neuronal development, maturation, and migration, 
as well as lesions in the maternal placenta. The amount 
of research accumulated in Zika since the beginning of 
the epidemic is huge, and the pathology of infectious 
diseases plays a decisive role. More recently, during 
the yellow fever epidemic in Brazil from 2017 to 2019, 
previous and current pathology studies have allowed 
a better understanding of the pathogenesis of the 
disease.6-9 In our region, where hemorrhagic fevers are 
endemic (e.g., dengue, leptospirosis, spotted fever, 
hantavirus, sepsis), the emergence of yellow fever has 
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become a problem for clinicians and epidemiologists. 
The pathologist’s action is decisive for the definition 
and exclusion of suspected cases, especially fatal ones, 
allowing accurate knowledge of the mortality rate and 
the magnitude of the problem.
What about super-resistant bacteria? In general, 
the literature describes the pathology caused by 
pyogenic bacteria, whether gram-positive cocci or 
gram-negative bacilli, as a suppurative inflammatory 
process, which is indistinguishable between agents 
regardless of antimicrobial susceptibility profiles.10 
In particular, I disagree with this point of view, at 
least partially. Little is known about the pathology of 
multidrug-resistant bacteria, and studies—even case 
reports—are extremely welcome as is Larry Nichols’ 
report Death from pan-resistant superbug, in this issue 
of Autopsy & Case Reports, describing the autopsy of 
a α-1-antitrypsin deficient patient who was a chronic 
corticosteroid user and developed fatal pneumonia 
caused by Acinetobacter baumannii resistant to all 
tested antibiotics.11 The description of the pathology 
of multi-resistant pyogenic agents may raise relevant 
insights for understanding the pathogenesis of 
infection and the virulence of an agent. For example, 
Pseudomonas aeruginosa, is a gram-negative bacillus, 
which causes pyogenic infection, with a particular 
vascular tropism inducing coagulative vessel necrosis 
and ischemic tissue damage.12
In the case described by Nichols, I am struck by 
the predominantly macrophage inflammatory response 
Figure 1. Pathology of viral infection. A – Fatal respiratory syncytial virus pneumonia in an infant. The arrows 
show a polykariotic infected pulmonary epithelial cell, with eosinophilic rounded cytoplasmic inclusion; B – Fatal 
Measles pneumonia (Hecht pneumonia) in a child under treatment for non-Hodgkin lymphoma. The arrows show 
multinucleated giant cells (Warthin-Finkeldey cells), with nuclear and cytoplasmic eosinophilic inclusions; C – Fatal 
dengue shock syndrome, with the typical mid-zonal hepatitis (arrow), with more preserved hepatocytes near to 
periportal area. The inflammatory tissue reaction is mild; D – The liver in a case with fulminant yellow fever. Similar to 
severe dengue, there is a mid-zonal hepatitis with numerous steatotic and apoptotic hepatocytes. The inflammatory 
reaction is also mild, with mononuclear infiltrate mainly located in the portal tracts. H&E stain. Magnification. 
A, B – 400x, C –100x, D – 300x.
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with a large number of bacteria phagocytized by alveolar 
macrophages (Figure 2 of the article). Some hypotheses 
may arise for this morphological scenario, which may 
be answered in the future by controlled experimental 
studies: is the macrophage response effective in 
destroying A. baumannii? Are the macrophages 
present type M1 or M2? Are the neutrophil response, 
complement, and antibodies compromised? It should 
be considered that the patient was a chronic user of 
corticosteroids. However, are there particularities in 
A. baumannii virulence? Some of these pathogenetic 
responses, if answered, may allow the discovery of 
new therapies. Therefore, the relevance of a detailed 
description of the pathology of multi-resistant 
superbugs. As a note, some autopsies of A. baumannii 
pneumonia recently performed by Departamento de 
Patologia – Faculdade de Medicina da Universidade de 
São Paulo (personal observation, unpublished data), 
present the same morphological findings as described 
by Nichols. Of course, detailed pathology studies with 
larger numbers of resistant bacteria with different 
phenotypic susceptibility patterns would provide more 
information on pathogenesis. Perhaps it would only 
be possible through the interaction between different 
health centers around the world.
The history of the pathology of infectious diseases 
coincides with the history of general pathology and 
modern medicine itself. From the earliest descriptions 
of the pathology of tuberculosis and yellow fever to the 
discovery of AIDS13-15; the Ebola epidemic in the 1990s16; 
the Bacillus anthracis bioterrorism attack in the early 
2000s17; the epidemics of SARS and pandemic influenza 
throughout the 2000s18,19; and more recently the Zika 
epidemic,3-5 with congenital syndrome, the pathology of 
infectious diseases plays a decisive role in understanding 
the pathogenesis of an infectious agent. Moreover, the 
pathology of infectious diseases is part of preparedness 
in case of an epidemic, as it defines or excludes the 
diagnosis of a disease. With this medical and social 
function, the pathology of infectious diseases can reach 
the fullness of its importance with the autopsy, when the 
pathologist examines all organs of a fatal case, allowing 
him/her to determine the mechanism of transmission, 
the mechanism of injury through the involvement of all 
organ systems, and to determine the cause of death. Of 
equal importance, the pathologist can characterize the 
individual’s in situ immune response, and predict the 
prognosis of an infectious disease and the therapeutic 
response by analyzing tissue damage.20-22
The arsenal of methodologies used by the 
pathologist for diagnosing infectious disease is mostly 
based on classic, low-cost techniques that require 
familiarity and expertise with the morphological aspect 
of the agents to complete their report: hematoxylin and 
eosin, and special stains such as Grocott, Ziehl-Neelsen, 
period acid-Schiff, Mucicarmine, Giemsa, and others.23 
Added to them is indispensable electron microscopy 
(EM). Perhaps it is in the field of infectious diseases 
where the great importance of EM still lies, and it is 
worth maintaining the technique and art of this old 
ancillary method. EM can elucidate difficult cases 
by discovering the etiology of a disease (especially 
viruses), in glutaraldehyde-fixed or paraffin-embedded 
tissues during epidemics, where immunohistochemistry 
antibodies or polymerase chain reaction (PCR) 
primers are not yet available.24 Molecular biology 
techniques such as in situ hybridization, PCR and gene 
sequencing—including next generation sequencing—
are new methods that can be used with frozen or fixed 
tissues; however, these techniques are not always 
available in resource-poor regions (Figure 2).25
The  expert in infectious disease pathology can act 
beyond the autopsy and analysis of surgical specimens 
(biopsies, cytology). The pathologist can assist research 
groups in evaluating the pathology of experimental 
models of infectious diseases and, within the new 
concept of “one health,” interact with veterinarians, 
environmentalists, and epidemiologists in epidemic 
situations or in comparative pathology studies of 
zoonoses (e.g., leptospirosis, yellow fever, spotty fever, 
west Nile, etc.).26
Considering all that has been commented 
on previously regarding the importance of the 
pathology of tropical infectious diseases, a recent 
review article, written by Hofman et al.,25 points out 
that this specialty needs to grow all over the world, 
stimulating the formation of young pathologists with 
expertise in this field. To reach this aim, stimulus 
must be created to attract resources to include new 
diagnostic methodologies in the field and to establish 
research, education, and patient-care networks, where 
specialists from different regions of the world can be 
connected to exchange knowledge.25
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